All three tumours had BRCA1-like characteristics, i.e. were triple negative (negative estrogen/progesterone receptor (ER/PR) and HER2 receptor status normal), basal-like subtype and had BRCA1 loss of heterozygosity (LOH). Here, ESR1 is linked to neoplasm.